{"bill":{"bill_id":1358028,"change_hash":"e3c09298fecd69cd642c3a0acffee381","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB6155\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6155\/all-info","completed":0,"status":1,"status_date":"2020-03-09","progress":[{"date":"2020-03-09","event":1},{"date":"2020-03-09","event":9}],"state":"US","state_id":52,"bill_number":"HB6155","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.","description":"To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2020-03-09","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-03-09","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-03-09","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":16460,"person_hash":"ntqo7c9d","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Glenn Grothman","first_name":"Glenn","middle_name":"","last_name":"Grothman","suffix":"","nickname":"","district":"HD-WI-6","ftm_eid":2927726,"votesmart_id":3493,"opensecrets_id":"N00036409","knowwho_pid":199967,"ballotpedia":"Glenn_Grothman","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"HB19","sast_bill_id":1287821},{"type_id":8,"type":"Related","sast_bill_number":"HB5444","sast_bill_id":1292107},{"type_id":8,"type":"Related","sast_bill_number":"SB1895","sast_bill_id":1269526},{"type_id":8,"type":"Related","sast_bill_number":"SB2103","sast_bill_id":1271403}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2173820,"date":"2020-03-18","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB6155\/id\/2173820","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr6155\/BILLS-116hr6155ih.pdf","text_size":320873,"text_hash":"b7cc9d429655742425be44a80101a333"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}